INCY Presents VGA039 Data
INCY Star Therapeutics is presenting complete data from a Phase 1/2 multidose study of VGA039 in Von Willebrand Disease at the ISTH 2026 Congress
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.